Glaucoma Drainage Implants in Pediatric Patients
Overview
Authors
Affiliations
To assess the use of drainage implants in pediatric patients with glaucoma refractory to conventional medical and surgical therapy, we retrospectively reviewed 20 consecutive eyes in children 10 years of age or younger treated with 16 Molteno (three of which were removed and replaced with second Molteno shunts) and seven Baerveldt implants. The age of the patients ranged from 1 month to 10 years (mean, 3 years). The patients had undergone a mean of two previous failed glaucoma procedures (range, one to six). The mean intraocular pressure (IOP) prior to drainage tube implantation was 37 +/- 4 mm Hg, compared with a mean of 18 +/- 6 mm Hg following surgery, with average postoperative follow up of 25 months (range, 8 to 41 months). The overall success, defined as IOP < or = 21 mm Hg without further surgical therapy, was 80%. Postoperative glaucoma medications were required in 75% of patients. There were 23 complications, one of which resulted in decreased visual acuity. These findings demonstrate that drainage tube implants can be effective in lowering IOP in uncontrolled pediatric glaucomas. Patients often require postoperative glaucoma medications and close monitoring for complications.
Risk and Prognostic Factors for Glaucoma Associated with Peters Anomaly.
Yokota C, Hirooka K, Okada N, Kiuchi Y J Clin Med. 2023; 12(19).
PMID: 37834882 PMC: 10573105. DOI: 10.3390/jcm12196238.
Ahmed to Baerveldt glaucoma drainage device exchange in pediatric patients.
Jacobson A, Bohnsack B BMC Ophthalmol. 2023; 23(1):310.
PMID: 37434139 PMC: 10334620. DOI: 10.1186/s12886-023-03074-1.
Stallworth J, OBrien K, Han Y, Oatts J Surv Ophthalmol. 2023; 68(4):578-590.
PMID: 36740196 PMC: 10293048. DOI: 10.1016/j.survophthal.2023.01.010.
Ologen augmentation of Ahmed glaucoma drainage devices in pediatric glaucomas.
Jacobson A, Rojas C, Bohnsack B BMC Ophthalmol. 2021; 21(1):72.
PMID: 33546636 PMC: 7863366. DOI: 10.1186/s12886-021-01827-4.
Rolim-de-Moura C, Esporcatte B, F Netto C, Paranhos Jr A Arq Bras Oftalmol. 2020; 83(3):215-224.
PMID: 32490976 PMC: 11826650. DOI: 10.5935/0004-2749.20200060.